214 results
Page 3 of 11
424B3
sunwn24
3 Mar 21
Prospectus supplement
5:01pm
POS AM
lrcz2
26 Feb 21
Prospectus update (post-effective amendment)
4:02pm
POS AM
mpfz3zdlkdu6 9v
12 Feb 21
Prospectus update (post-effective amendment)
4:32pm
8-K
EX-4.1
09q23twoov
14 Jan 21
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
5:13pm
8-K
EX-4.2
zwz6g6iddtdzg9uz1
14 Jan 21
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
5:13pm
8-K
EX-4.3
egzq39ud7llwhhhgceg
14 Jan 21
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
5:13pm
8-K
EX-1.1
uw4vveldvyyppr31uem
14 Jan 21
Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering
5:13pm
424B4
y18th 5ircpn9w
14 Jan 21
Prospectus supplement with pricing info
12:00am